NCT01186328 2024-02-01
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1 Terminated
Therapeutic Advances in Childhood Leukemia Consortium
OHSU Knight Cancer Institute
European Organisation for Research and Treatment of Cancer - EORTC